Submission for OMB Review; 30-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIH), 27458-27459 [2021-10665]
Download as PDF
<![CDATA[
27458
Federal Register / Vol. 86, No. 96 / Thursday, May 20, 2021 / Notices
74 The Wilton Rancheria, California had Federal recognition restored in July 2009 as documented at 74 FR 33468, July 13, 2009. Sacramento
County, CA, was designated administratively as part of the Rancheria’s CHSDA in addition to the CHSDA established by Congress for the State
of California. Sacramento County was not covered when Congress originally established the State of California as a CHSDA excluding certain
counties including Sacramento County (25 U.S.C. 1680).
75 Public Law 100–89, Restoration Act for Ysleta Del Sur and Alabama and Coushatta Tribes of Texas establishes service areas for ‘‘members
of the Tribe’’ by sections 101(3) and 105(a) for the Pueblo and sections 201(3) and 206(a) respectively.
Elizabeth A. Fowler,
Acting Director, Indian Health Service.
[FR Doc. 2021–10661 Filed 5–19–21; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; HEAL Initiative: Pain
Therapeutics Development (Small Molecules
and Biologics).
Date: June 14, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Rockville, MD 20852,
(301) 435–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Blueprint Neurotherapeutics
Network Small Molecule Drug Discovery for
Disorders of the Nervous System.
Date: June 18, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Joel A. Saydoff, Ph.D.,
Scientific Review Officer, Scientific Review
VerDate Sep<11>2014
17:36 May 19, 2021
Jkt 253001
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Room 3205, MSC 9529, Rockville, MD 20852,
(301) 496–9223, joel.saydoff@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders B (NSD–B) Study Section.
Date: June 24–25, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Joel A. Saydoff, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Room 3205, MSC 9529, Rockville, MD 20852,
(301) 496–9223 joel.saydoff@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 14, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10625 Filed 5–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Clinical Trials and Translational
Research Advisory Committee.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: July 14, 2021.
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
Time: 11:00 a.m. to 2:00 p.m.
Agenda: Strategic Discussion of NCI’s
Clinical and Translational Research
Programs.
Place: National Cancer Institute, 9609
Medical Center Drive, Rockville, MD 20850
(Virtual Meeting).
Contact Person: Sheila A. Prindiville, MD,
M.P.H., Director, Coordinating Center for
Clinical Trials, National Cancer Institute,
National Institutes of Health, 9609 Medical
Center Drive, Room 6W136, Rockville, MD
20850, 240–276–6173, prindivs@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 17, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10678 Filed 5–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
(NIH)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
SUMMARY:
E:\FR\FM\20MYN1.SGM
20MYN1
27459
Federal Register / Vol. 86, No. 96 / Thursday, May 20, 2021 / Notices
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Tawanda
Abdelmouti, Assistant Project Officer,
Office of Policy for Extramural Research
Administration, 6705 Rockledge Drive,
Suite 350, Bethesda, Maryland 20892 or
call non-toll-free number (301) 435–
0978 or email your request, including
your address to: abdelmot@
mail.nih.gov.
This
proposed information collection was
previously published in the Federal
Register on January 21, 2021, page 6355
(86 FR 6355) and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. National Institutes
of Health (NIH), may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery, EXTENSION, 0925–0648,
expiration date 05/31/2021, National
Institutes of Health (NIH).
SUPPLEMENTARY INFORMATION:
Need and Use of Information
Collection: There are no changes being
requested for this submission. The
information collection activity will
garner qualitative customer and
stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. This generic
will provide information about the NIH
Institutes and Centers customer or
stakeholder perceptions, experiences,
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training, or changes in
operations might improve delivery of
products or services. It will also allow
feedback to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
49,333.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of collection
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hour
Customer Satisfaction Surveys .....................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ................................
Focus Groups ................................................................................................
Usability and Pilot Testing .............................................................................
Conference/Training—Pre-and Post-Surveys ...............................................
1,000
1,000
1,000
150,000
100,000
1
1
1
1
2
30/60
90/60
90/60
5/60
10/60
500
1,500
1,500
12,500
33,333
Total ........................................................................................................
253,000
353,000
........................
49,333
Dated: May 13, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2021–10665 Filed 5–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Sep<11>2014
17:36 May 19, 2021
Jkt 253001
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel:
Fellowship and Career Development.
Date: June 4, 2021.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, 6701 Democracy Blvd., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Weiqun Li, MD, Scientific
Review Officer, National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Blvd., Ste. 710, Bethesda, MD
20892, (301) 594–5966, wli@mail.nih.gov.
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: May 17, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10684 Filed 5–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
E:\FR\FM\20MYN1.SGM
20MYN1
]]>Agencies
[Federal Register Volume 86, Number 96 (Thursday, May 20, 2021)]
[Notices]
[Pages 27458-27459]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10665]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Generic
Clearance for the Collection of Qualitative Feedback on Agency Service
Delivery (NIH)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review
[[Page 27459]]
and approval of the information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Ms. Tawanda Abdelmouti, Assistant Project
Officer, Office of Policy for Extramural Research Administration, 6705
Rockledge Drive, Suite 350, Bethesda, Maryland 20892 or call non-toll-
free number (301) 435-0978 or email your request, including your
address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on January 21, 2021, page
6355 (86 FR 6355) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. National Institutes of Health
(NIH), may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Generic Clearance for the Collection of
Qualitative Feedback on Agency Service Delivery, EXTENSION, 0925-0648,
expiration date 05/31/2021, National Institutes of Health (NIH).
Need and Use of Information Collection: There are no changes being
requested for this submission. The information collection activity will
garner qualitative customer and stakeholder feedback in an efficient,
timely manner, in accordance with the Administration's commitment to
improving service delivery. This generic will provide information about
the NIH Institutes and Centers customer or stakeholder perceptions,
experiences, and expectations, provide an early warning of issues with
service, or focus attention on areas where communication, training, or
changes in operations might improve delivery of products or services.
It will also allow feedback to contribute directly to the improvement
of program management. Feedback collected under this generic clearance
will provide useful information, but it will not yield data that can be
generalized to the overall population.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 49,333.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of collection Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Customer Satisfaction Surveys.................. 1,000 1 30/60 500
In-Depth Interviews (IDIs) or Small Discussion 1,000 1 90/60 1,500
Groups........................................
Focus Groups................................... 1,000 1 90/60 1,500
Usability and Pilot Testing.................... 150,000 1 5/60 12,500
Conference/Training--Pre-and Post-Surveys...... 100,000 2 10/60 33,333
----------------------------------------------------------------
Total...................................... 253,000 353,000 .............. 49,333
----------------------------------------------------------------------------------------------------------------
Dated: May 13, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-10665 Filed 5-19-21; 8:45 am]
BILLING CODE 4140-01-P
